Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system

Osteosarcoma is the most common type primary malignant tumor of bone. Patients with regional osteosarcoma are routinely treated with surgery and chemotherapy. In addition, many patients with metastatic or recurrent osteosarcoma show poor prognosis with current chemotherapy agents. Therefore, it is i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Orthop Res
Egile Nagusiak: Feng, Yong, Sassi, Slim, Shen, Jacson K, Yang, Xiaoqian, Gao, Yan, Osaka, Eiji, Zhang, Jianming, Yang, Shuhua, Yang, Cao, Mankin, Henry J., Hornicek, Francis J, Duan, Zhenfeng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4304907/
https://ncbi.nlm.nih.gov/pubmed/25348612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.22745
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak